Cargando…
S197: LINKER-MM1 STUDY: LINVOSELTAMAB (REGN5458) IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA
Autores principales: | , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428402/ http://dx.doi.org/10.1097/01.HS9.0000967700.16100.68 |
_version_ | 1785090460502458368 |
---|---|
author | Lee, Hans C. Bumma, Naresh Richter, Joshua Dhodapkar, Madhav Hoffman, James E. Suvannasankha, Attaya Zonder, Jeffrey Shah, Mansi R. Lentzsch, Suzanne Maly, Joseph J. Ye, Jing Christine Wu, Ka Lung Deveaux, Michelle Chokshi, Dhruti Boyapati, Anita Hazra, Anasuya Lorenc, Karen Rodriguez Kroog, Glenn Houvras, Yariv Jagannath, Sundar |
author_facet | Lee, Hans C. Bumma, Naresh Richter, Joshua Dhodapkar, Madhav Hoffman, James E. Suvannasankha, Attaya Zonder, Jeffrey Shah, Mansi R. Lentzsch, Suzanne Maly, Joseph J. Ye, Jing Christine Wu, Ka Lung Deveaux, Michelle Chokshi, Dhruti Boyapati, Anita Hazra, Anasuya Lorenc, Karen Rodriguez Kroog, Glenn Houvras, Yariv Jagannath, Sundar |
author_sort | Lee, Hans C. |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-10428402 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-104284022023-08-17 S197: LINKER-MM1 STUDY: LINVOSELTAMAB (REGN5458) IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA Lee, Hans C. Bumma, Naresh Richter, Joshua Dhodapkar, Madhav Hoffman, James E. Suvannasankha, Attaya Zonder, Jeffrey Shah, Mansi R. Lentzsch, Suzanne Maly, Joseph J. Ye, Jing Christine Wu, Ka Lung Deveaux, Michelle Chokshi, Dhruti Boyapati, Anita Hazra, Anasuya Lorenc, Karen Rodriguez Kroog, Glenn Houvras, Yariv Jagannath, Sundar Hemasphere Oral Sessions Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10428402/ http://dx.doi.org/10.1097/01.HS9.0000967700.16100.68 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
spellingShingle | Oral Sessions Lee, Hans C. Bumma, Naresh Richter, Joshua Dhodapkar, Madhav Hoffman, James E. Suvannasankha, Attaya Zonder, Jeffrey Shah, Mansi R. Lentzsch, Suzanne Maly, Joseph J. Ye, Jing Christine Wu, Ka Lung Deveaux, Michelle Chokshi, Dhruti Boyapati, Anita Hazra, Anasuya Lorenc, Karen Rodriguez Kroog, Glenn Houvras, Yariv Jagannath, Sundar S197: LINKER-MM1 STUDY: LINVOSELTAMAB (REGN5458) IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA |
title | S197: LINKER-MM1 STUDY: LINVOSELTAMAB (REGN5458) IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA |
title_full | S197: LINKER-MM1 STUDY: LINVOSELTAMAB (REGN5458) IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA |
title_fullStr | S197: LINKER-MM1 STUDY: LINVOSELTAMAB (REGN5458) IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA |
title_full_unstemmed | S197: LINKER-MM1 STUDY: LINVOSELTAMAB (REGN5458) IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA |
title_short | S197: LINKER-MM1 STUDY: LINVOSELTAMAB (REGN5458) IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA |
title_sort | s197: linker-mm1 study: linvoseltamab (regn5458) in patients with relapsed/refractory multiple myeloma |
topic | Oral Sessions |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428402/ http://dx.doi.org/10.1097/01.HS9.0000967700.16100.68 |
work_keys_str_mv | AT leehansc s197linkermm1studylinvoseltamabregn5458inpatientswithrelapsedrefractorymultiplemyeloma AT bummanaresh s197linkermm1studylinvoseltamabregn5458inpatientswithrelapsedrefractorymultiplemyeloma AT richterjoshua s197linkermm1studylinvoseltamabregn5458inpatientswithrelapsedrefractorymultiplemyeloma AT dhodapkarmadhav s197linkermm1studylinvoseltamabregn5458inpatientswithrelapsedrefractorymultiplemyeloma AT hoffmanjamese s197linkermm1studylinvoseltamabregn5458inpatientswithrelapsedrefractorymultiplemyeloma AT suvannasankhaattaya s197linkermm1studylinvoseltamabregn5458inpatientswithrelapsedrefractorymultiplemyeloma AT zonderjeffrey s197linkermm1studylinvoseltamabregn5458inpatientswithrelapsedrefractorymultiplemyeloma AT shahmansir s197linkermm1studylinvoseltamabregn5458inpatientswithrelapsedrefractorymultiplemyeloma AT lentzschsuzanne s197linkermm1studylinvoseltamabregn5458inpatientswithrelapsedrefractorymultiplemyeloma AT malyjosephj s197linkermm1studylinvoseltamabregn5458inpatientswithrelapsedrefractorymultiplemyeloma AT yejingchristine s197linkermm1studylinvoseltamabregn5458inpatientswithrelapsedrefractorymultiplemyeloma AT wukalung s197linkermm1studylinvoseltamabregn5458inpatientswithrelapsedrefractorymultiplemyeloma AT deveauxmichelle s197linkermm1studylinvoseltamabregn5458inpatientswithrelapsedrefractorymultiplemyeloma AT chokshidhruti s197linkermm1studylinvoseltamabregn5458inpatientswithrelapsedrefractorymultiplemyeloma AT boyapatianita s197linkermm1studylinvoseltamabregn5458inpatientswithrelapsedrefractorymultiplemyeloma AT hazraanasuya s197linkermm1studylinvoseltamabregn5458inpatientswithrelapsedrefractorymultiplemyeloma AT lorenckarenrodriguez s197linkermm1studylinvoseltamabregn5458inpatientswithrelapsedrefractorymultiplemyeloma AT kroogglenn s197linkermm1studylinvoseltamabregn5458inpatientswithrelapsedrefractorymultiplemyeloma AT houvrasyariv s197linkermm1studylinvoseltamabregn5458inpatientswithrelapsedrefractorymultiplemyeloma AT jagannathsundar s197linkermm1studylinvoseltamabregn5458inpatientswithrelapsedrefractorymultiplemyeloma |